Related Experiment Video
Updated: Aug 12, 2026

Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation
Published on: November 10, 2023
Pulmonary airflow obstruction following lymphography
Abstract:
In a series of 27 patients a significant mean decrease of forced expiratory volume in one second (FEV1) was recorded at 1/2, 2, 4 and 24 hours after lymphography with an oily contrast medium, with a maximum mean decrease at 4 hours after injection. The decrease of FEV1 was greater in patients given large amounts of contrast medium at high injection speed. Furthermore, an excessive decrease was observed in patients with metastatic lymph nodes, while a less marked decrease of FEV1 was observed in patients treated with aspirin. No serious clinical side effects were observed. It is recommended that the injection speed and the total amount of contrast medium be limited as far as possible, especially in patients with severe airflow obstruction or with metastases in the lymphatic system. Oral administration of aspirin may limit the decrease in FEV1 following lymphography.
Related Concept Videos
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Pneumothorax-II
Clinical Manifestations:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

